financetom
Business
financetom
/
Business
/
Cadre Holdings Insider Sold Shares Worth $3,348,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cadre Holdings Insider Sold Shares Worth $3,348,000, According to a Recent SEC Filing
Jun 23, 2025 1:46 PM

04:28 PM EDT, 06/23/2025 (MT Newswires) -- Warren B Kanders, 10% Owner, Director, CEO, and Chairman, on June 18, 2025, sold 100,000 shares in Cadre Holdings ( CDRE ) for $3,348,000. Following the Form 4 filing with the SEC, Kanders has control over a total of 11,615,876 common shares of the company, with 45,584 shares held directly and 11,570,292 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1860543/000110465925061677/xslF345X05/tm2518657-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stifel Financial to Acquire Investment Bank Bryan Garnier
Stifel Financial to Acquire Investment Bank Bryan Garnier
Jan 6, 2025
09:17 AM EST, 01/06/2025 (MT Newswires) -- Stifel Financial ( SF ) said Monday it has agreed to buy investment bank Bryan Garnier. Financial terms of the deal weren't provided. Bryan Garnier, which is focused on European tech and healthcare companies, has its headquarters in Paris and offices in London, Amsterdam, Munich, Oslo, Stockholm and New York, Stifel said. ...
Teoxane offers superior proposal to acquire Revance Therapeutics
Teoxane offers superior proposal to acquire Revance Therapeutics
Jan 6, 2025
Jan 6 (Reuters) - Teoxane SA offered to acquire Revance Therapeutics ( RVNC ) for a higher price compared to a buyout offer from Crown Laboratories last month. Teoxane's proposal provides a 16% premium over the $3.10 per share price in Revance's merger agreement with Crown Laboratories on Dec. 9. (Reporting by Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli)...
Castle Biosciences Says TissueCypher Test Approved by New York Health Department
Castle Biosciences Says TissueCypher Test Approved by New York Health Department
Jan 6, 2025
09:23 AM EST, 01/06/2025 (MT Newswires) -- Castle Biosciences ( CSTL ) said Monday it has received approval from the New York State Department of Health for its TissueCypher test, a tool designed to assess the risk of progression from Barrett's esophagus to esophageal cancer. The company said the approval expands its New York Clinical Laboratory Permit to include this...
Why Is Employment Agency Company GEE Group Stock Surging Today?
Why Is Employment Agency Company GEE Group Stock Surging Today?
Jan 6, 2025
GEE Group Inc. ( JOB ) shares are surging premarket on Monday after the company acquired Hornet Staffing, Inc., a provider of IT, professional, and customer service staffing solutions for large-scale clients, for an undisclosed amount. GEE Group ( JOB ) purchased 100% of Hornet’s common stock through a combination of cash and seller financing. The Hornet acquisition boosts GEE...
Copyright 2023-2026 - www.financetom.com All Rights Reserved